Growth Metrics

Merck (MRK) Income from Continuing Operations (2016 - 2026)

Merck has reported Income from Continuing Operations over the past 18 years, most recently at 4209000000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations fell 182.77% to 4209000000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 8968000000.0 through Mar 2026, down 48.61% year-over-year, with the annual reading at 18263000000.0 for FY2025, 6.6% up from the prior year.
  • Income from Continuing Operations was 4209000000.0 for Q1 2026 at Merck, down from 2962000000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 5787000000.0 in Q3 2025 and troughed at 5937000000.0 in Q2 2023.
  • The 5-year median for Income from Continuing Operations is 3744000000.0 (2024), against an average of 2713235294.12.
  • Year-over-year, Income from Continuing Operations tumbled 250.34% in 2023 and then soared 405.38% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 3018000000.0 in 2022, then tumbled by 140.62% to 1226000000.0 in 2023, then soared by 405.38% to 3744000000.0 in 2024, then decreased by 20.89% to 2962000000.0 in 2025, then tumbled by 242.1% to 4209000000.0 in 2026.
  • Per Business Quant, the three most recent readings for MRK's Income from Continuing Operations are 4209000000.0 (Q1 2026), 2962000000.0 (Q4 2025), and 5787000000.0 (Q3 2025).